Terms: = Endocrine gland cancer AND PMS1, hPMS1, 5378, ENSG00000064933, PMSL1, HNPCC3, DKFZp781M0253
25 results:
1. Analysis of 11 candidate genes in 849 adult patients with suspected hereditary cancer predisposition.
Cavaillé M; Uhrhammer N; Privat M; Ponelle-Chachuat F; Gay-Bellile M; Lepage M; Molnar I; Viala S; Bidet Y; Bignon YJ
Genes Chromosomes Cancer; 2021 Feb; 60(2):73-78. PubMed ID: 33099839
[TBL] [Abstract] [Full Text] [Related]
2. Performance characteristics of screening strategies to identify Lynch syndrome in women with ovarian cancer.
Kim SR; Tone A; Kim RH; Cesari M; Clarke BA; Eiriksson L; Hart T; Aronson M; Holter S; Lytwyn A; Maganti M; Oldfield L; Gallinger S; Bernardini MQ; Oza AM; Djordjevic B; Lerner-Ellis J; Van de Laar E; Vicus D; Pugh TJ; Pollett A; Ferguson SE
Cancer; 2020 Nov; 126(22):4886-4894. PubMed ID: 32809219
[TBL] [Abstract] [Full Text] [Related]
3. Germline and somatic mutations of multi-gene panel in Chinese patients with epithelial ovarian cancer: a prospective cohort study.
Li W; Shao D; Li L; Wu M; Ma S; Tan X; Zhong S; Guo F; Wang Z; Ye M
J Ovarian Res; 2019 Aug; 12(1):80. PubMed ID: 31472684
[TBL] [Abstract] [Full Text] [Related]
4. DNA Mismatch Repair Deficiency Promotes Genomic Instability in a Subset of Papillary Thyroid cancers.
Javid M; Sasanakietkul T; Nicolson NG; Gibson CE; Callender GG; Korah R; Carling T
World J Surg; 2018 Feb; 42(2):358-366. PubMed ID: 29075860
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic values of DNA mismatch repair genes in ovarian cancer patients treated with platinum-based chemotherapy.
Zhao C; Li S; Zhao M; Zhu H; Zhu X
Arch Gynecol Obstet; 2018 Jan; 297(1):153-159. PubMed ID: 29063235
[TBL] [Abstract] [Full Text] [Related]
6. Primary multiple tumor with affection of the thyroid gland, uterus, urinary bladder, mammary gland and other organs.
Romaniuk А; Lyndin M; Smiyanov V; Sikora V; Rieznik A; Kuzenko Y; Budko H; Moskalenko Y; Karpenko L; Sikora V; Gladchenko O
Pathol Res Pract; 2017 May; 213(5):574-579. PubMed ID: 28214212
[TBL] [Abstract] [Full Text] [Related]
7. Parathyroid dual tracer subtraction scintigraphy: small regions method for quantitative assessment of parathyroid adenoma uptake.
Koljević Marković A; Janković MM; Marković I; Pupić G; Džodić R; Delaloye AB
Ann Nucl Med; 2014 Oct; 28(8):736-45. PubMed ID: 24947176
[TBL] [Abstract] [Full Text] [Related]
8. Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes.
Castéra L; Krieger S; Rousselin A; Legros A; Baumann JJ; Bruet O; Brault B; Fouillet R; Goardon N; Letac O; Baert-Desurmont S; Tinat J; Bera O; Dugast C; Berthet P; Polycarpe F; Layet V; Hardouin A; Frébourg T; Vaur D
Eur J Hum Genet; 2014 Nov; 22(11):1305-13. PubMed ID: 24549055
[TBL] [Abstract] [Full Text] [Related]
9. Mismatch repair deficiency in ovarian cancer -- molecular characteristics and clinical implications.
Xiao X; Melton DW; Gourley C
Gynecol Oncol; 2014 Feb; 132(2):506-12. PubMed ID: 24333356
[TBL] [Abstract] [Full Text] [Related]
10. Hereditary breast and ovarian cancer susceptibility genes (review).
Kobayashi H; Ohno S; Sasaki Y; Matsuura M
Oncol Rep; 2013 Sep; 30(3):1019-29. PubMed ID: 23779253
[TBL] [Abstract] [Full Text] [Related]
11. [Hereditary ovarian cancer. The role of BRCA1 gene dysfunction in response to chemotherapy].
Blecharz P; Karolewski K; Urbański K
Ginekol Pol; 2011 Mar; 82(3):214-20. PubMed ID: 21735691
[TBL] [Abstract] [Full Text] [Related]
12. Mismatch repair gene polymorphisms and survival in invasive ovarian cancer patients.
Mann A; Hogdall E; Ramus SJ; DiCioccio RA; Hogdall C; Quaye L; McGuire V; Whittemore AS; Shah M; Greenberg D; Easton DF; Ponder BA; Kjaer SK; Gayther SA; Thompson DJ; Pharoah PD; Song H
Eur J Cancer; 2008 Oct; 44(15):2259-65. PubMed ID: 18723338
[TBL] [Abstract] [Full Text] [Related]
13. Analysis of DNA mismatch repair gene expression and mutations in thyroid tumours.
Ruschenburg I; Vollheim B; Stachura J; Cordon-Cardo C; Korabiowska M
Anticancer Res; 2006; 26(3A):2107-12. PubMed ID: 16827152
[TBL] [Abstract] [Full Text] [Related]
14. Common variants in mismatch repair genes and risk of invasive ovarian cancer.
Song H; Ramus SJ; Quaye L; DiCioccio RA; Tyrer J; Lomas E; Shadforth D; Hogdall E; Hogdall C; McGuire V; Whittemore AS; Easton DF; Ponder BA; Kjaer SK; Pharoah PD; Gayther SA
Carcinogenesis; 2006 Nov; 27(11):2235-42. PubMed ID: 16774946
[TBL] [Abstract] [Full Text] [Related]
15. Immune responses to DNA mismatch repair enzymes hMSH2 and hpms1 in patients with pancreatic cancer, dermatomyositis and polymyositis.
Okada T; Noji S; Goto Y; Iwata T; Fujita T; Okada T; Matsuzaki Y; Kuwana M; Hirakata M; Horii A; Matsuno S; Sunamura M; Kawakami Y
Int J Cancer; 2005 Oct; 116(6):925-33. PubMed ID: 15856462
[TBL] [Abstract] [Full Text] [Related]
16. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
Geisler JP; Goodheart MJ; Sood AK; Holmes RJ; Hatterman-Zogg MA; Buller RE
Cancer; 2003 Nov; 98(10):2199-206. PubMed ID: 14601090
[TBL] [Abstract] [Full Text] [Related]
17. Chemotherapy resistant ovarian cancer in carriers of an hMSH2 mutation?
Marcelis CL; van der Putten HW; Tops C; Lutgens LC; Moog U
Fam Cancer; 2001; 1(2):107-9. PubMed ID: 14574006
[TBL] [Abstract] [Full Text] [Related]
18. Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index.
Tanaka Y; Hongo K; Tada T; Sakai K; Kakizawa Y; Kobayashi S
J Neurosurg; 2003 Feb; 98(2):359-65. PubMed ID: 12593623
[TBL] [Abstract] [Full Text] [Related]
19. Pancreatic cancer genetics.
Efthimiou E; Crnogorac-Jurcevic T; Lemoine NR
Pancreatology; 2001; 1(6):571-5. PubMed ID: 12120238
[TBL] [Abstract] [Full Text] [Related]
20. [From gene to disease; from DNA 'mismatch' repair genes to hereditary non-polyposis colorectal carcinoma].
Wijnen JT; Morreau H; Vasen HF
Ned Tijdschr Geneeskd; 2001 Apr; 145(16):780-2. PubMed ID: 11346916
[TBL] [Abstract] [Full Text] [Related]
[Next]
